Keller Eric L.insider trades
In SEC Form 4 filings, Keller Eric L. is listed as CHIEF EXECUTIVE OFFICER of Retension Pharmaceuticals, Inc. (RTSN). In the last 90 days, Keller Eric L. bought $249.6K of Retension Pharmaceuticals, Inc. (RTSN) on the open market and sold none. The purchase was $249.6K of Retension Pharmaceuticals, Inc. (RTSN) on Oct 13. Took part in a cluster buy; the latest at Retension Pharmaceuticals, Inc. (RTSN), where 2 insiders bought within 1 day, ending Oct 13.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| RTSNRetension Pharmaceuticals, Inc. | CHIEF EXECUTIVE OFFICER | 7 | Oct 22 |
Cluster buys
- RTSN: 2 insiders bought $369.6K between Oct 13.
Form 4 historysince 2026-10-13
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| RTSNRetension Pharmaceuticals, Inc. | Oct 22 | Oct 22 | A · derivative | 40,884 | $15.50 | $633,702 | 40,884 | No | Form 4 |
| RTSNRetension Pharmaceuticals, Inc. | Oct 13 | Oct 13 | P | 20,800 | $12.00 | Purchase +$249,600 | 423,377 | No | Form 4 |
| RTSNRetension Pharmaceuticals, Inc. | Oct 13 | Oct 13 | C | 9,662 | not reported | not reported | 433,039 | No | Form 4 |
| RTSNRetension Pharmaceuticals, Inc. | Oct 13 | Oct 13 | C | 31,368 | not reported | not reported | 464,407 | No | Form 4 |
| RTSNRetension Pharmaceuticals, Inc. | Oct 13 | Oct 13 | A · derivative | 255,174 | $11.63 | $2,967,674 | 255,174 | No | Form 4 |
| RTSNRetension Pharmaceuticals, Inc. | Oct 13 | Oct 13 | C · derivative | 9,662 | not reported | not reported | not reported | No | Form 4 |
| RTSNRetension Pharmaceuticals, Inc. | Oct 13 | Oct 13 | C · derivative | 31,368 | not reported | not reported | not reported | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.